Stocks that are Rising/Falling And Why (3 December 2018)

by NaturalHedgehog

Each day I go through the top rising and falling stocks today, and look for (a) what the company actually does, and (b) why the stock is moving so much. Hopefully this saves you some digging!

Below are my notes from 3 December 2018 as of mid-morning. (This list is limited to companies with market cap >$500 million, and also excludes VIX, short ETFs, etc, as these just reflect the market, rather than individual companies.)

Today Company Driving the stock
58% TESARO, Inc. (TSRO) GSK buying Tesaro for $5.1 billion (Pharma, cancer therapeutics)
46% Global Blood Therapeutics, Inc. (GBT) FDA agreed to accelerated approval pathway for sickle cell disease drug (Pharma, blood-based diseases)
18% Cronos Group Inc. (CRON) Rumor that Altria will be Cronos (Cannabis)
17% Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Announced positive data from a Phase 3 clinical trial for Zydis, an oral tablet for migraines (Pharma)
16% Vanda Pharmaceuticals Inc. (VNDA) Announced positive data from a Phase 2 clinical trial for tradipitant (Pharma, nervous system therapies)
12% Clovis Oncology, Inc. (CLVS) Unclear, likely jumping due to Tesaro acquisition (Pharma, cancer therapeutics)
READ  Bitcoin, Real Estate, Stocks...they're just the first outlets of a hyperinflationary cycle. Eventually assets need to be sold for real life needs.
Today Company Driving the stock
-19% Aphria Inc (APHA) Short sellers allege fraud (Cannabis)
-11% Arlo Technologies Inc (ARLO) Warned Q4 revenue was below expectations (Home camera security maker)
-10% Agios Pharmaceuticals, Inc. (AGIO) Unclear, likely due to update on clinical trial (Pharma, cancer therapies)
-10% VS 2X VIX Short Term (TVIX) Vix volatile due to market turmoil
-9% Discovery, Inc. (DISCA) CEO David Zaslav said at an industry conference that the Discovery Channel “has some ratings challenges” (Cable)
-8% GlaxoSmithKline PLC (GSK) Investors react negatively to GSK buying Tesaro for hefty $5.1 billion (Pharma)
READ  Here’s What $1,000 Invested in Vaccine Stocks Would Be Worth Now




Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.